Back to Journals » Drug Design, Development and Therapy » Volume 15 » A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Subjects
Please verify you are not a robot.